Clinical Trial Update: Levetiracetam for Benign Rolandic Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating levetiracetam for Benign Rolandic Epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Rolandic Epilepsy

Drugs mentioned

• Levetiracetam (Keppra) (levetiracetam)

Snippet

Sponsor: Johns Hopkins University | Conditions: Epilepsy | Phase 4 | Status: COMPLETED